Live Chat Software

Interviews

Tools of the Trace

Tools of the Trace

Past speaker Peter Sturtevant, Sr. Director of Industry Engagement at GS1 US, discusses the tools which will help you achieve and surpass DSCSA compliance, such as the Electronic Product Code Information Service and the Master Data Exchange. 

McKesson on: The Largest Challenges in Preparing for DSCSA Saleable Returns Verification

McKesson on: The Largest Challenges in Preparing for DSCSA Saleable Returns Verification

We caught up with Kevan MacKenzie, Director of Serialization Technology at McKesson, to learn about wholesaler-distributors largest challenges in preparing for DSCSA saleable returns verification in 2019.

In addition to discussing wholesaler-distributors current challenges, MacKenzie also reveals: 

  • His advice for those who are experiencing difficulty in getting ready for saleable returns and exception management
  • The implications that varying global regulations creates for wholesaler-distributors 
  • A look at where the industry currently stands regarding interoperability and what it will take to meet the 2023 deadline
  • What you can expect to learn from his presentation at the upcoming Pharmaceutical Traceability Forum this November in Philadelphia 
  • And more!
Expert Insight into Top Pharmaceutical Challenges Surrounding Serialization: Aggregation and CMO Integration

Expert Insight into Top Pharmaceutical Challenges Surrounding Serialization: Aggregation and CMO Integration

In anticipation of the Pharmaceutical Traceability Forum, we spoke with Matt Sample and Christopher Howell about the top pharmaceutical challenges surrounding Serialization: Aggregation and CMO Integration. Both speakers shared their unique perspectives on the topic and also expressed what they were most excited to learn about at the upcoming event. 

FDA Vision For 2023

FDA Vision For 2023

Ahead of the 6th Pharmaceutical Traceability Forum, December 7 -8, we interviewed members of our speaker faculty on their immediate impressions of the FDA meeting that was held in August. Get your copy of this exclusive interview to find out what the FDA vision of the future is for 2023!